240 related articles for article (PubMed ID: 23288448)
1. Novel mannich bases, 5-arylimidazolidine-2,4-dione derivatives with dual 5-HT(1A) receptor and serotonin transporter affinity.
Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Siwek A; Bojarski AJ; Bednarski M; Wróbel D; Wesołowska A
Arch Pharm (Weinheim); 2013 Feb; 346(2):98-109. PubMed ID: 23288448
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity.
Czopek A; Byrtus H; Kołaczkowski M; Pawłowski M; Dybała M; Nowak G; Tatarczyńska E; Wesołowska A; Chojnacka-Wójcik E
Eur J Med Chem; 2010 Apr; 45(4):1295-303. PubMed ID: 20060623
[TBL] [Abstract][Full Text] [Related]
3. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and 5-HT(1A), 5-HT(2A) receptor activity of new beta-tetralonohydantoins.
Byrtus H; Pawłowski M; Czopek A; Bojarski AJ; Duszyńska B; Nowak G; Kłodzińska A; Tatarczyńska E; Wesołowska A; Chojnacka-Wójcik E
Eur J Med Chem; 2005 Aug; 40(8):820-9. PubMed ID: 16122584
[TBL] [Abstract][Full Text] [Related]
5. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E; Pawłowski M; Martinez J
Bioorg Med Chem; 2007 Apr; 15(8):2907-19. PubMed ID: 17321139
[TBL] [Abstract][Full Text] [Related]
6. Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.
Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Kazek G; Bojarski AJ; Piaskowska A; Kalinowska-Tłuścik J; Partyka A; Wesołowska A
Bioorg Med Chem; 2015 Jul; 23(13):3436-47. PubMed ID: 25936259
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
Wróbel MZ; Chodkowski A; Herold F; Gomółka A; Kleps J; Mazurek AP; Pluciński F; Mazurek A; Nowak G; Siwek A; Stachowicz K; Sławińska A; Wolak M; Szewczyk B; Satała G; Bojarski AJ; Turło J
Eur J Med Chem; 2013 May; 63():484-500. PubMed ID: 23524160
[TBL] [Abstract][Full Text] [Related]
8. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
[TBL] [Abstract][Full Text] [Related]
9. Further optimization of novel pyrrole 3-carboxamides for targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.
Kang SY; Park EJ; Park WK; Kim HJ; Choi G; Jung ME; Seo HJ; Kim MJ; Pae AN; Kim J; Lee J
Bioorg Med Chem; 2010 Aug; 18(16):6156-69. PubMed ID: 20637635
[TBL] [Abstract][Full Text] [Related]
10. Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines.
Mewshaw RE; Zhou D; Zhou P; Shi X; Hornby G; Spangler T; Scerni R; Smith D; Schechter LE; Andree TH
J Med Chem; 2004 Jul; 47(15):3823-42. PubMed ID: 15239661
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
Kucwaj-Brysz K; Kurczab R; Jastrzębska-Więsek M; Żesławska E; Satała G; Nitek W; Partyka A; Siwek A; Jankowska A; Wesołowska A; Kieć-Kononowicz K; Handzlik J
Eur J Med Chem; 2018 Mar; 147():102-114. PubMed ID: 29425815
[TBL] [Abstract][Full Text] [Related]
12. Optimization of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT₇ receptor antagonist activity.
Volk B; Gacsályi I; Pallagi K; Poszávácz L; Gyönös I; Szabó E; Bakó T; Spedding M; Simig G; Szénási G
J Med Chem; 2011 Oct; 54(19):6657-69. PubMed ID: 21859099
[TBL] [Abstract][Full Text] [Related]
13. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor.
Perrone R; Berardi F; Colabufo NA; Lacivita E; Larizza C; Leopoldo M; Tortorella V
J Pharm Pharmacol; 2005 Oct; 57(10):1319-27. PubMed ID: 16259761
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents.
Zagórska A; Bucki A; Kołaczkowski M; Siwek A; Głuch-Lutwin M; Starowicz G; Kazek G; Partyka A; Wesołowska A; Słoczyńska K; Pękala E; Pawłowski M
J Enzyme Inhib Med Chem; 2016; 31(sup3):10-24. PubMed ID: 27353547
[TBL] [Abstract][Full Text] [Related]
16. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of [(4-arylpiperazin-1-yl)-alkyl]-carbamic acid ethyl ester derivatives as potential anxiolytic agents.
Khatri M; Rai SK; Ranbhor R; Kishore K; Tiwari M
Arch Pharm Res; 2012 Jul; 35(7):1143-52. PubMed ID: 22864736
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant- and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 5-HT₁A receptor functional profile.
Partyka A; Chłoń-Rzepa G; Wasik A; Jastrzębska-Więsek M; Bucki A; Kołaczkowski M; Satała G; Bojarski AJ; Wesołowska A
Bioorg Med Chem; 2015 Jan; 23(1):212-21. PubMed ID: 25435254
[TBL] [Abstract][Full Text] [Related]
19. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
[TBL] [Abstract][Full Text] [Related]
20. 7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT(1A), 5-HT(2A), and 5-HT(7) serotonin receptor ligands.
Chłoń-Rzepa G; Zmudzki P; Zajdel P; Bojarski AJ; Duszyńska B; Nikiforuk A; Tatarczyńska E; Pawłowski M
Bioorg Med Chem; 2007 Aug; 15(15):5239-50. PubMed ID: 17517514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
